RNA on Nasdaq

Avidity Biosciences

American Biotech Company.1

Price unavailable

Last updated Oct 16, 2026.

Overview

Compare with Sol-Gel Technologies Ltd., Evofem Biosciences, Inc. or SCYNEXIS INC, or pick any stock.

  • TickerRNA on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersDE1
  • Incorporated inDE3
  • Business address3020 Callan Road, San Diego, Ca 921213
  • Filer category, Emerging growth company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-3977.3%Operating margin4
-3650.4%Net margin4
72.1%Revenue growth, 20254
-40.5%Return on equity4
-$663.8MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Research and development100¢$559.2M

Out of $18.8M in revenue.4 The company lost money this year.

Financial statements

Revenue56784$18.8M in 2025+709% since 2019
0$5.0M$10.0M$15.0M$20.0M2019: $2.3M$2.3M20192020: $6.8M$6.8M2020+193%2021: $9.3M$9.3M2021+37%2022: $9.2M$9.2M2022−1%2023: $9.6M$9.6M2023+4%2024: $10.9M$10.9M2024+14%2025: $18.8M$18.8M2025+72%
Operating income56784-$745.9M in 2025+4204% since 2019
-$800.0M-$600.0M-$400.0M-$200.0M02019: -$17.3M-$17.3M20192020: -$44.3M-$44.3M2020+155%2021: -$118.1M-$118.1M2021+167%2022: -$178.9M-$178.9M2022+52%2023: -$235.6M-$235.6M2023+32%2024: -$378.9M-$378.9M2024+61%2025: -$745.9M-$745.9M2025+97%
Net income56784-$684.6M in 2025+2668% since 2019
-$800.0M-$600.0M-$400.0M-$200.0M02019: -$24.7M-$24.7M20192020: -$44.4M-$44.4M2020+79%2021: -$118.0M-$118.0M2021+166%2022: -$174.0M-$174.0M2022+47%2023: -$212.2M-$212.2M2023+22%2024: -$322.3M-$322.3M2024+52%2025: -$684.6M-$684.6M2025+112%
Fiscal year2019202020212022202320242025
Revenue$2.3M5$6.8M6$9.3M7$9.2M8$9.6M4$10.9M4$18.8M4
Research and development$14.5M5$37.6M6$101.2M7$150.4M8$191.0M4$303.6M4$559.2M4
Operating income-$17.3M5-$44.3M6-$118.1M7-$178.9M8-$235.6M4-$378.9M4-$745.9M4
Interest$7.4M5$209.0K6$06$06
Income tax$05$06$07$08$04$04$04
Net income-$24.7M5-$44.4M6-$118.0M7-$174.0M8-$212.2M4-$322.3M4-$684.6M4
Earnings per share-$2.056-$2.857-$3.348-$2.914-$2.894-$4.974
Earnings per share (diluted)-$2.056-$2.857-$3.348-$2.914-$2.894-$4.974

Compare Avidity Biosciences with another company

Subsidiaries and ownership

Parent company

From Wikidata.1

Timeline

  1. Jun 6, 2020Went public Listed on NASDAQ1

Recent filings

  1. Oct 9, 20268-K/A
  2. Oct 8, 20268-K
  3. Sep 22, 20264
  4. Sep 22, 20264
  5. Sep 22, 20264
  6. Sep 22, 20264
  7. Sep 22, 20264
  8. Sep 22, 20264
  9. Sep 22, 20264
  10. Sep 22, 20264
  11. Aug 14, 2026SCHEDULE 13G/A
  12. Aug 14, 2026SCHEDULE 13G
  13. Aug 14, 2026SCHEDULE 13G/A
  14. Aug 13, 20268-K
  15. Aug 13, 202610-Q

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11